A latest report has been added to the wide database of Heparin Market by Infinium Global Research. This
report studies the Heparin Market by product type (unfractionated, low molecular, ultra-molecular weight
heparin), route of administration (iv injection, subcutaneous injection), application (clinical trials, medical
devices), end user (hospital, blood, steam banks) market status and outlook of global and major regions, from
manufacturers, and end industries. The objective of the study is to identify market sizes of different segments
& countries in recent years and to forecast the values for the next six years. Heparin Market provides
opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive
landscape, latest trends, and product offerings of the major companies in the Heparin Market. According to
the report the Global Heparin Market is projected to grow at a CAGR of 5.91% in terms of value over the
period of 2017-2023. Globally, the heparin market is growing steadily due to increasing incidences of
coagulation disorders, substantial growth in the number of the people suffering from diseases like venous
thromboembolism (VTE), deep vein thrombosis and heart diseases. In addition, the considerable rise in the
prevalence of the obesity is also expected to support the global growth of this market.
However, stringent regulatory framework across different regions and side effects of the porcine heparin are
likely to limit the global growth of heparin market. A heparin market is expected to experience adoption of
synthetic heparin by leading players in the industry. With adoption of synthetic heparin, the global market is
anticipated to augment the opportunities for the leading market player in the industry over the forecast
period. Furthermore, Technological advancement and rising demand for heparin also expected to escalate
growth in this market over the forecast period.
Segments Covered:
The report segments the global heparin market by type of product, route of administration, application, end
users and regions. Product segment includes unfractionated heparin, low molecular weight heparin (LMWH)
and ultra-molecular weight heparin (UMWH). Route of administration segment comprises IV injection,
Infinium Global Research